These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 483255)

  • 1. Formation and dissociation of soluble fibrin complexes in plasma at 20 degrees C and at 37 degrees C.
    Müller-Berghaus G; Mahn I; Krell W
    Thromb Res; 1979; 14(4-5):561-72. PubMed ID: 483255
    [No Abstract]   [Full Text] [Related]  

  • 2. Gel filtration of 125I-fibrin and 131I-fibrinogen at 20 degrees C and 37 degrees C.
    Krell W; Mahn I; Müller-Berghaus G
    Thromb Res; 1979; 14(2-3):299-310. PubMed ID: 442008
    [No Abstract]   [Full Text] [Related]  

  • 3. Separation of human des-AB fibrin and fibrinogen by sepharose-plasma chromatography at 20 degrees C and 37 degrees C.
    Mahn I; Krell W; Müller-Berghaus G
    Thromb Res; 1979; 14(4-5):651-63. PubMed ID: 483260
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 5. Equilibrium binding studies of des-AB fibrin and fibrinogen by gel filtration at 20 degrees c and 37 degrees c.
    Mahn I; Krell W; Müller-Berghaus G
    Thromb Res; 1980 Mar; 17(5):623-7. PubMed ID: 7385098
    [No Abstract]   [Full Text] [Related]  

  • 6. Stabilization of soluble fibrin-fibrinogen complexes by fibrin stabilizing factor (FSF).
    Ly B; Kierulf P; Jakobsen E
    Thromb Res; 1974 Apr; 4(4):509-22. PubMed ID: 4429641
    [No Abstract]   [Full Text] [Related]  

  • 7. Different chromatographic behaviour of soluble, non-FSF-stabilized des-AA fibrin/fibrinogen and des-AABB fibrin/fibrinogen complexes.
    Brosstad F
    Thromb Res; 1979; 15(3-4):563-8. PubMed ID: 40318
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative assessment of soluble fibrin in plasma by affinity chromatography--a comparative study with desAA-fibrin, desAABB-fibrin and fibrinogen.
    Thiel W; Delvos U; Müller-Berghaus G
    Thromb Haemost; 1985 Aug; 54(2):533-8. PubMed ID: 4082091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble crosslinked fibrin(ogen) polymers.
    Selmayr E; Müller-Berghaus G
    Thromb Haemost; 1985 Dec; 54(4):804-7. PubMed ID: 4089815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and dissociation of soluble fibrin in vivo.
    Mahn I; Schönbach F; Müller-Berghaus G
    Thromb Res; 1977 Jul; 11(1):67-80. PubMed ID: 888120
    [No Abstract]   [Full Text] [Related]  

  • 11. Affinity chromatography of soluble fibrin in human plasma on insolubilized fibrinogen and fragment D.
    Semeraro N; Collen D
    Thromb Res; 1978 Jun; 12(6):1059-70. PubMed ID: 694816
    [No Abstract]   [Full Text] [Related]  

  • 12. The in vivo behavior of the terminal derivatives of fibrinogen and fibrin cleaved by plasmin.
    Catanzaro A; Edgington TS
    J Lab Clin Med; 1974 Mar; 83(3):458-66. PubMed ID: 4272970
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 14. Incorporation of fibrinogen into soluble fibrin complexes.
    Jakobsen E; Ly B; Kierulf P
    Thromb Res; 1974 Apr; 4(4):499-507. PubMed ID: 4428463
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro formation and i vivo clearance of fibrinogen: fibrin complexes.
    Sherman LA; Harwig S; Lee J
    J Lab Clin Med; 1975 Jul; 86(1):100-11. PubMed ID: 1151132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble fibrin monomer complexes demonstrated by agarose gel filtration and by adsorption on insolubilized fibrinogen: a comparative study.
    von Hugo R; Stemberger A; Graeff H
    Thromb Diath Haemorrh; 1975 Sep; 34(1):216-22. PubMed ID: 1188711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tanned red cell hemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products. Methodological and statistical aspects.
    Hahn L
    Thromb Res; 1974 Mar; 4(3):417-36. PubMed ID: 4857332
    [No Abstract]   [Full Text] [Related]  

  • 18. Properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Mosesson MW
    Thromb Diath Haemorrh Suppl; 1973; 56():75-90. PubMed ID: 4218377
    [No Abstract]   [Full Text] [Related]  

  • 19. Incorporation of 125 I-fibrinogen in circulating soluble fibrin monomer complexes during hypercoagulability.
    von Hugo R; Hafter R; Stein B; Stemberger A; Rjosk H; Graeff H
    Thromb Res; 1977 May; 10(5):703-10. PubMed ID: 329464
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary fibrin-fibrinogen degradation products and intraglomerular fibrin-fibrinogen deposition in various renal diseases.
    Kamitsuji H; Tani K; Taniguchi A; Masuyama H; Iida Y; Fukui H
    Thromb Res; 1981 Feb; 21(3):285-94. PubMed ID: 7245140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.